Skip to main content

Kelly CRISPR & Gene Editing Technology ETF

Open-end / ETF
Registrant
Strategic Trust
Net Assets
$2,586,186
Holdings
25
Latest Report
Nov 30, 2023

Net Assets Over Time

Holdings · 25

Export CSV
Holding Balance Value % of Fund Open
CRISPR Therapeutics AG
5,698 $380,228 14.70%
Verve Therapeutics Inc
9,968 $112,439 4.35%
Poseida Therapeutics Inc
41,412 $110,570 4.28%
Sanofi SA
910 $84,853 3.28%
Novartis AG
812 $79,486 3.07%
2seventy bio Inc
24,724 $45,245 1.75%
Precision BioSciences Inc
62,664 $22,252 0.86%
QIAGEN NV
448 $18,440 0.71%
First American Government Obli
4,850 $4,850 0.19%
First American Treasury Obliga
4,850 $4,850 0.19%